G

Gerald M. McInerney

Karolinska Institutet

ORCID: 0000-0003-2257-7241

Publishes on SARS-CoV-2 and COVID-19 Research, Mosquito-borne diseases and control, COVID-19 Clinical Research Studies. 140 papers and 16.4k citations.

PubIndex Score65Top 35% · seniorHow it's scored

140Publications

16.4kTotal Citations

First publication: 2000First senior author: 2004

SARS-CoV-2 and COVID-19 Research Mosquito-borne diseases and control COVID-19 Clinical Research Studies interferon and immune responses Viral Infections and Immunology Research

Top publicationsby citations

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction

Leo Hanke, Gerald M. McInerney|Nature Communications|2020

Cited by 359

A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo

Leo Hanke, Gerald M. McInerney|Nature Communications|2022

Cited by 86

Alphavirus-induced hyperactivation of PI3K/AKT directs pro-viral metabolic changes

Michela Mazzon, Gerald M. McInerney|PLoS Pathogens|2018

Cited by 63

SARS-CoV-2 N protein recruits G3BP to double membrane vesicles to promote translation of viral mRNAs

Siwen Long, Gerald M. McInerney|Nature Communications|2024

Cited by 11

A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 <i>in vivo</i>

Leo Hanke, Gerald M. McInerney|bioRxiv (Cold Spring Harbor Laboratory)|2021

Cited by 6